Antimalarial Atovaquone May Improve Lung Cancer Treatment Outcomes

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Antimalarial pharmacology and therapeutics of atovaquone

Atovaquone is used as a fixed-dose combination with proguanil (Malarone) for treating children and adults with uncomplicated malaria or as chemoprophylaxis for preventing malaria in travellers. Indeed, in the USA, between 2009 and 2011, Malarone prescriptions accounted for 70% of all antimalarial pre-travel prescriptions. In 2013 the patent for Malarone will expire, potentially resulting in a w...

متن کامل

Minimally Invasive Strategies To Evaluate and Treat Lung Lesions May Improve Cancer Outcomes

For more information and to register, visit nyp.org/pro or e-mail [email protected] Minimally Invasive Strategies To Evaluate and Treat Lung Lesions May Improve Cancer Outcomes A t NewYork-Presbyterian Hospital, minimally invasive methods to confirm and stage lung cancer are complementing broad efforts to improve outcomes in the most common cause of cancer death. Many suspicious pulmonary nodules...

متن کامل

treatment of gastro-esophageal reflux disease may improve surgical outcomes for chronic otitis media

background this study has been designed to investigate the clinical association between gastro esophageal reflux disease (gerd) and chronic otitis media (com) in adults and also the role of gerd treatment on the outcome of com surgery. methods in a randomized clinical trial, 58 patients with com who were candidates for surgery were evaluated for gerd and divided in two groups; gerd posi­tive (c...

متن کامل

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.

Recently, it was reported that sera from healthy volunteers given atovaquone-proguanil (Malarone) inhibited parasite transmission and asexual blood stage development for up to 6 weeks after treatment (1). The lengthy persistence of drug activity was quite unexpected because earlier studies had shown that proguanil and atovaquone had elimination halflives of about 14 to 20 h (2–4, 10, 11) and 2 ...

متن کامل

Lung cancer treatment outcomes in recipients of lung transplant.

BACKGROUND Lung transplant recipients develop lung cancer more commonly than the general population. The best treatment approach for these patients is unclear. The goal of this study is to evaluate treatment outcomes in this population. METHODS We used the Cleveland Clinic lung transplant database to identify patients diagnosed with lung cancer at the time of or after lung transplant. Transpl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Oncology Times

سال: 2021

ISSN: 0276-2234

DOI: 10.1097/01.cot.0000749928.39408.89